灌注栓塞联合无水酒精注射治疗肝癌42例分析

【目的】评价肝动脉栓塞 (TACE)联合经皮穿刺瘤体内注射无水酒精 (PEI)治疗原发型肝癌的临床疗效。【方法】 4 2例原发型肝癌分为 2组 ,A组 (联合治疗组 ) 2 2例应用TACE +PEI治疗。B组 :(对照组 ) 2 0例应用单纯 (TACE)治疗。【结果】联合治疗组肿瘤缩小率、肿瘤组织坏死率均明显高于对照组。患者 12、 2 4、36、 4 2m生存率具有显著性差异 (P <0 0 5 )。【结论】肝动脉栓塞联合经皮穿刺瘤体内注射无水酒精是治疗中晚期肝癌安全、有效的综合治疗方法。

The treatment of liver cancer by transcatheter arteridal chemoembolization(TACE) combined with percutaneous ethanol injection(PEI)

To evaluate the clinically curative effect of primary liver cancers treated with TACE combined with PEI.Forty two cases of primary liver cancers were divided into two groups,Group A(combined treatment group)consisting of twenty two cases and Group B(control group) including twenty cases.Group Awas treated with TACE and PEI while Group B was treated with TACE only.In the combined treatment group,the rate of atrophy of the tumours,the rate of decent of the blood serum AFP and the rate of necrosis of tumor organism were evidently higher than these of the control group.The probability of patients surviving in one year,two years,three years or three and a half years was distinctively different(P<0.05).[Conclusion]TACE combined with PEI is a safe and effective method for treating intermediate and late liver cancer.It can increase the pronbbility of patients surviving.